Metabolic PET Imaging as an early biomarker of cardiac toxicity following treatment with the tyrosine kinase inhibitor sunitinib

被引：0
|
作者：
Byrne, Annette T. [1 ]
机构：
[1] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Lab Tumour Biol & Mol Imaging, Dublin 2, Ireland
来源：
ANGIOGENESIS | 2014年 / 17卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
O-38
引用
收藏
页码：726 / 727
页数：2
相关论文
共 50 条
  • [31] Tyrosine Kinase Inhibitor Sunitinib Targets the Vasculature of Clear Cell Renal Cell Carcinoma: A Histological and Immunocytochemical Study of Treatment Effect
    Huang, J.
    Thomas, A.
    Simmerman, K.
    Sercia, L.
    Magi-Galluzzi, C.
    Campbell, S.
    Rini, B.
    Zhou, M.
    MODERN PATHOLOGY, 2010, 23 : 197A - 197A
  • [32] Tyrosine Kinase Inhibitor Sunitinib Targets the Vasculature of Clear Cell Renal Cell Carcinoma: A Histological and Immunocytochemical Study of Treatment Effect
    Huang, J.
    Thomas, A.
    Simmerman, K.
    Sercia, L.
    Magi-Galluzzi, C.
    Campbell, S.
    Rini, B.
    Zhou, M.
    LABORATORY INVESTIGATION, 2010, 90 : 197A - 197A
  • [33] Serum creatine kinase elevation following tyrosine kinase inhibitor treatment in cancer patients: Symptoms, mechanism, and clinical management
    Zhang, Hang
    To, Kenneth K. W.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (11):
  • [34] FDG PET/CT as imaging biomarker in the era of molecular targeting therapies: sequential FDG PET/CT demonstrated biological response and acquisition of resistance to tyrosine kinase inhibitor therapy for renal cell carcinoma
    Nakaigawa, N.
    Namura, K.
    Ueno, D.
    Tateishi, U.
    Inoue, T.
    Yao, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 154 - 154
  • [35] The use of the tyrosine kinase inhibitor Nilotinib in Spondyloarthritis: does targeting inflammatory pathways with a treatment lead to vascular toxicity?
    Loukman Omarjee
    Vincent Jaquinandi
    Guillaume Mahe
    Journal of Translational Medicine, 15
  • [36] The use of the tyrosine kinase inhibitor Nilotinib in Spondyloarthritis: does targeting inflammatory pathways with a treatment lead to vascular toxicity?
    Omarjee, Loukman
    Jaquinandi, Vincent
    Mahe, Guillaume
    JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [37] Diverse Spectrum of ABL1 Kinase Gene Mutations in Ph plus Leukemias Following Tyrosine Kinase Inhibitor Treatment
    Bischof, L. J.
    Weigelin, H. C.
    Betz, B. L.
    Elenitoba-Johnson, K. S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 630 - 630
  • [38] The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma
    Helena Polena
    Julie Creuzet
    Maeva Dufies
    Adama Sidibé
    Abir Khalil-Mgharbel
    Aude Salomon
    Alban Deroux
    Jean-Louis Quesada
    Caroline Roelants
    Odile Filhol
    Claude Cochet
    Ellen Blanc
    Céline Ferlay-Segura
    Delphine Borchiellini
    Jean-Marc Ferrero
    Bernard Escudier
    Sylvie Négrier
    Gilles Pages
    Isabelle Vilgrain
    British Journal of Cancer, 2018, 118 : 1179 - 1188
  • [39] The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma
    Polena, Helena
    Creuzet, Julie
    Dufies, Maeva
    Sidibe, Adama
    Khalil-Mgharbel, Abir
    Salomon, Aude
    Deroux, Alban
    Quesada, Jean-Louis
    Roelants, Caroline
    Filhol, Odile
    Cochet, Claude
    Blanc, Ellen
    Ferlay-Segura, Celine
    Borchiellini, Delphine
    Ferrero, Jean-Marc
    Escudier, Bernard
    Negrier, Sylvie
    Pages, Gilles
    Vilgrain, Isabelle
    BRITISH JOURNAL OF CANCER, 2018, 118 (09) : 1179 - 1188
  • [40] Dosimetry of 18F-Labeled Tyrosine Kinase Inhibitor SKI-249380, a Dasatinib-Tracer for PET Imaging
    Dunphy, Mark P. S.
    Zanzonico, Pat
    Veach, Darren
    Somwar, Romel
    Pillarsetty, Nagavarakishore
    Lewis, Jason
    Larson, Steven
    MOLECULAR IMAGING AND BIOLOGY, 2012, 14 (01) : 25 - 31
12345